Advisor Group’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $28K | Hold |
440
| – | – | ﹤0.01% | 3751 |
|
|
2019
Q3 | $26K | Hold |
440
| – | – | ﹤0.01% | 3780 |
|
|
2019
Q2 | $26K | Buy |
440
+133
| +43% | +$7.86K | ﹤0.01% | 3783 |
|
|
2019
Q1 | $20K | Buy |
307
+67
| +28% | +$4.37K | ﹤0.01% | 3964 |
|
|
2018
Q4 | $12K | Hold |
240
| – | – | ﹤0.01% | 4081 |
|
|
2018
Q3 | $13K | Buy |
240
+7
| +3% | +$379 | ﹤0.01% | 4112 |
|
|
2018
Q2 | $14K | Buy |
233
+66
| +40% | +$3.97K | ﹤0.01% | 3894 |
|
|
2018
Q1 | $8K | Hold |
167
| – | – | ﹤0.01% | 4186 |
|
|
2017
Q4 | $10K | Buy |
167
+34
| +26% | +$2.04K | ﹤0.01% | 4067 |
|
|
2017
Q3 | $8K | Buy |
133
+33
| +33% | +$1.99K | ﹤0.01% | 4067 |
|
|
2017
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 4150 |
|
|
2017
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 4015 |
|
|
2016
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 3995 |
|
|
2016
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 3961 |
|
|
2016
Q2 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 3945 |
|